Maxillary undifferentiated high-grade pleomorphic sarcoma: A case report and review of the literature

Abstract

Undifferentiated high-grade pleomorphic sarcoma is a tumor of mesenchymal cells without clear cell differentiation and represents a diagnosis of exclusion. It is located mainly in extremities, so its location in the head and neck is extremely rare. We report the case of an undifferentiated high-grade pleomorphic sarcoma located on the hard palate.

Keywords

Sarcoma / Undifferentiated / High-grade / Pleomorphic / Lung / Metastases

CONFLICTS OF INTEREST DISCLOSURE

Authors declare have no interest conflict.

References

[1] Vuity D, Bogdan S, Csurgay K, et al. Malignant Fibrous Histiocytoma/Undifferentiated High-Grade Pleomorphic Sarcoma of the Maxillary Sinus. Pathol Oncol Res. 2013; 19: 605-9. PMid: 23812657. http://dx.doi.org/10.1007/s12253-013-9640-2

[2] Fletcher CDM, Unni KK, Mertens F, et al. World Health Organization classification of tumors. Pathology and genetics of tumours of soft tissue and bone. Lyon: IARC; 2002.

[3] Fletcher CDM. The evolving classification of soft tissue tumours: an update based on the new WHO classification. Histopathology. 2006; 48: 3-12. PMid: 16359532. http://dx.doi.org/10.1111/j.1365-2559.2005.02284.x

[4] Bentz BG, Singh B, Woodruff J, et al. Head and neck soft tissue sarcomas: a multivariate analysis of outcomes. Ann Surg Oncol. 2004; 11: 619-28. PMid: 15172935. http://dx.doi.org/10.1245/ASO.2004.03.006

[5] Dei Tos AP. Classification of pleomorphic sarcomas: where are we now? Histopathology. 2006; 48: 51-62. PMid: 16359537. http://dx.doi.org/10.1111/j.1365-2559.2005.02289.x

[6] Alfredo E, Vicentini E, Comelli R, et al. Oral undifferentiated highgrade pleomorphic sarcoma: report of a case. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 105: e37-40. PMid: 18155600. http://dx.doi.org/10.1016/j.tripleo.2007.07.023

[7] Mu-oz A, Mencía E, Cámara M, et al. Undifferentiated high-grade pleomorphic sarcoma of the orbit: A case report. Arch Soc Esp Oftalmol. 2014; 89(10): 425-7.

[8] Müller-Richter U, Katinka J, Reichert T, et al. Undifferentiated pleomorphic sarcoma of the orbital region. British Journal of Oral and Maxillofacial Surgery. 2008; 46: 325-7. PMid: 17681406. http://dx.doi.org/10.1016/j.bjoms.2007.06.007

[9] Vishpal D, Guttal K, Patil P, et al. Undifferentiated pleomorphic sarcoma of the left parotid gland: a case report. Oral Radiol. 2016. http://dx.doi.org/10.1007/s11282-016-0246-8

[10] Pobirci DD, Bogdan F, Pobirci O, et al. Study of malignant fibrous histiocytoma: clinical, statistic and histopatological interrelation. Rom J Morphol Embryol. 2011; 52 (1): 385-8. PMid: 21424079.

[11] Park SW, Kim HJ, Lee JH, et al. Malignant fibrous histiocytoma of the head and neck: CT and MR imaging findings. Am J Neuroradiol. 2009; 30: 71-6. PMid: 18842757. http://dx.doi.org/10.3174/ajnr.A1317

[12] Sarrami AH, Setareh M, Afshar-Moghaddam N, et al. A case of intracranial malignant fibrous histiocytoma. J Res Med Sci. 2011; 16: 968-73. PMid: 22279468.

[13] Guillou L. Pleomorphic sarcomas: subclassification, myogenic differentiation and prognosis. Diagnostic Histopathology. 2008; 14(11): 527-37. http://dx.doi.org/10.1016/j.mpdhp.2008.08.002

[14] Massi D, Beltrami G, Capanna R, et al. Histopathological reclassification of extremity pleomorphic soft tissue sarcoma has clinical relevance. Eur J Surg Oncol. 2004; 30: 1131-6. PMid: 15522563. http://dx.doi.org/10.1016/j.ejso.2004.07.018

[15] Matsumoto S, Ahmed AR, Kawaguchi N, et al. Results of surgery for malignant fibrous histiocytomas of soft tissue. Int J Clin Oncol. 2003; 8: 104-9. PMid: 12720103. http://dx.doi.org/10.1007/s101470300018

[16] Zagers GK, Ballo MT, Pisters PWT, et al. Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy. Cancer. 2003; 97: 2530-43. PMid: 12733153. http://dx.doi.org/10.1002/cncr.11365

[17] Sergio Obeso, José Luis Llorente, Juan Pablo Díaz-Molina, et al. Surgical treatment of head and neck chondrosarcomas. Acta Otorrinolaringol Esp. 2010; 61(4): 262-71. PMid: 20096816. http://dx.doi.org/10.1016/j.otorri.2009.12.002

[18] Gawande M, Swastika N, Chaudhary M, et al. Chondrosarcoma of maxilla. J Oral Maxillofac Pathol. 2014; 18: 423-7. PMid: 25949000. http://dx.doi.org/10.4103/0973-029X.151338

[19] Abdel-Fattah HM, Nasef HO, Fadali GAS, et al. Hyoid bone chondrosarcoma with cervical nodal metastasis: A case report. Alex J Med. 2015.

[20] Judson I, Verweij j, Gelderblom H, et al. Doxorubicin alone versus intensified doxorubicin plus ifosfamide for first-line treatment of advanced or metastatic soft-tissue sarcoma: a randomised controlled phase 3 trial. The Lancet Oncology. 2014; 15(4): 415-23. http://dx.doi.org/10.1016/s1470-2045(14)70063-4